roferon-a
roche products (nz) ltd - interferon alfa-2a 6 miu/ml; - solution for injection - 3miu/0.5ml - active: interferon alfa-2a 6 miu/ml excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).
roferon-a
roche products (nz) ltd - interferon alfa-2a 12 miu/ml; - solution for injection - 6miu/0.5ml - active: interferon alfa-2a 12 miu/ml excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).
roferon-a
roche products (nz) ltd - interferon alfa-2a 18 miu/ml; - solution for injection - 9miu/0.5ml - active: interferon alfa-2a 18 miu/ml excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).
roferon-a interferon alfa-2a 9 million iu/0.5ml injection pre-filled syringe
roche products pty ltd - interferon alfa-2a -
roferon-a inferferon alfa-2a 3 million iu/0.5ml injection pre-filled syringe
roche products pty ltd - interferon alfa-2a -
roferon-a
roche products pty ltd - interferon alfa-2a -
roferon-a prefilled syringe for injection 3 miu0.5 ml
roche singapore pte. ltd. - interferon alfa-2a - injection - 3 miu/0.5 ml - interferon alfa-2a 3 miu/0.5 ml
roferon-a solution for s/c injection
f. hoffmann-la roche ltd. - interferon alfa-2a - solution for s/c injection - 3000000iu/0,5ml
roferon a 4.5miu/0.5 %v/v solution for injection
roche products limited - interferon alfa-2a - solution for injection - 4.5miu/0.5 %v/v
roferon a 6miu/ml %v/v solution for injection
roche products limited - interferon alfa-2a - solution for injection - 6miu/ml %v/v